First Light Asset Management, Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$1.12B
Q ending 2026-03-31
Prior quarter
$1.31B
Q ending 2025-12-31
Change
-14.7% QoQ · +27.4% YoY
Positions
35
reported holdings
Largest positions
All 35 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Axogen Inc | AXGN | Shares | $132.6M | 4.0M |
| Palvella Therapeutics Inc | PVLA | Shares | $122.3M | 981K |
| Neogenomics Inc | NEO | Shares | $72.2M | 9.7M |
| Si-Bone Inc | SIBN | Shares | $67.6M | 5.4M |
| Centessa Pharmaceuticals Limited | 260 | Shares | $62.0M | 1.6M |
| Apogee Therapeutics Inc | APGE | Shares | $48.5M | 577K |
| Amylyx Pharmaceuticals Inc | AMLX | Shares | $44.3M | 3.2M |
| Twist Bioscience Corporation | TWST | Shares | $41.8M | 879K |
| Crinetics Pharmaceuticals Inc | CRNX | Shares | $39.6M | 1.1M |
| 908 Devices Inc | MASS | Shares | $37.2M | 6.1M |
| Neuropace Inc | NPCE | Shares | $32.3M | 2.5M |
| Edgewise Therapeutics Inc | EWTX | Shares | $31.6M | 1.0M |
| Anaptys Bio Inc | ANAB | Shares | $31.4M | 565K |
| Simulations Plus Inc | SLP | Shares | $31.1M | 2.6M |
| Guardant Health | GH | Shares | $25.9M | 280K |
| Tandem Diabetes Care Inc | TNDM | Shares | $25.2M | 1.3M |
| Atricure Inc | ATRC | Shares | $20.8M | 730K |
| Trisalus Life Sciences Inc | TLSI | Shares | $20.3M | 5.1M |
| Tectonic Therapeutics Inc | TECX | Shares | $20.0M | 648K |
| Irhythm Technologies | IRTC | Shares | $19.8M | 168K |
| Septerna Inc | SEPN | Shares | $17.6M | 733K |
| Establishment Labs Holdings | Shares | $17.5M | 308K | |
| Health Catalyst Inc | HCAT | Shares | $16.4M | 12.9M |
| Omnicell Inc | OMCL | Shares | $16.4M | 490K |
| Koru Medical Systems Inc | KRMD | Shares | $16.3M | 3.8M |
| Genedx Holdings Corp | WGS | Shares | $15.6M | 243K |
| Wave Life Sciences Ltd | Shares | $13.4M | 1.8M | |
| Vera Therapeutics Inc | VERA | Shares | $12.6M | 314K |
| Mimedx Group Inc | MDXG | Shares | $11.2M | 2.8M |
| Butterfly Network Inc | BFLY | Shares | $10.7M | 2.7M |
| Spyglass Pharma Inc | SGP | Shares | $9.7M | 375K |
| Organogenesis Holdings Inc | ORGO | Shares | $8.3M | 3.5M |
| Vaxcyte Inc | PCVX | Shares | $8.2M | 142K |
| Enliven Therapeutics Inc | ELVN | Shares | $7.9M | 202K |
| Rhythm Pharmaceuticals Inc | RYTM | Shares | $7.6M | 87K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.